Jackson Square Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-24,953
| Closed | -$1.52M | – | 147 |
|
2025
Q1 | $1.52M | Buy |
24,953
+747
| +3% | +$45.6K | 0.49% | 45 |
|
2024
Q4 | $1.37M | Buy |
+24,206
| New | +$1.37M | 0.33% | 57 |
|
2022
Q3 | – | Sell |
-7,952
| Closed | -$612K | – | 126 |
|
2022
Q2 | $612K | Hold |
7,952
| – | – | 0.26% | 76 |
|
2022
Q1 | $581K | Buy |
7,952
+3,526
| +80% | +$258K | 0.18% | 101 |
|
2021
Q4 | $276K | Sell |
4,426
-39,689
| -90% | -$2.47M | 0.08% | 170 |
|
2021
Q3 | $2.61M | Sell |
44,115
-631
| -1% | -$37.3K | 0.85% | 38 |
|
2021
Q2 | $2.99M | Sell |
44,746
-108
| -0.2% | -$7.22K | 0.96% | 36 |
|
2021
Q1 | $2.83M | Sell |
44,854
-2,358
| -5% | -$149K | 1.08% | 31 |
|
2020
Q4 | $2.93M | Sell |
47,212
-845
| -2% | -$52.4K | 1.13% | 33 |
|
2020
Q3 | $2.9M | Sell |
48,057
-785
| -2% | -$47.3K | 1.28% | 33 |
|
2020
Q2 | $2.87M | Buy |
48,842
+10,683
| +28% | +$628K | 1.45% | 26 |
|
2020
Q1 | $2.13M | Buy |
38,159
+35,316
| +1,242% | +$1.97M | 1.65% | 20 |
|
2019
Q4 | $182K | Buy |
+2,843
| New | +$182K | 0.11% | 100 |
|